1-4 of 4
Edward R. Broun, MD
Close
Sort by
Journal Articles

Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particularly in FLT3-ITD-Negative Patients: ECOG-ACRIN (E-A) E2906 Randomized Study

James M. Foran, MD, Zhuoxin Sun, David F. Claxton, MD, Hillard M Lazarus, MD, Daniel A. Arber, MD, Jacob M. Rowe, MB, BS, Elisabeth Paietta, PhD, Janis Racevskis, PhD, Jessica K. Altman, Selina M. Luger, MD FRCPC, Aref Al-Kali, MD, Hong Zheng, MD PhD, Keith W. Pratz, MD, Edward R. Broun, MD, Bayard L Powell, MD, Kristen Marie O'Dwyer, MD, John E. Godwin, MD, Yishai Ofran, MD, Mark Litzow, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 115.
https://doi.org/10.1182/blood-2019-129876
Published: 2019
Journal Articles

Minimal Residual Disease (MRD) at Time of Complete Remission Is Commonly Detected in Acute Myeloid Leukemia (AML) Patients Age ≥60 Years and Significantly Impacts Outcome Based on Post-Remission Treatment Strategies: Prospective Analysis of ECOG-ACRIN (E-A) E2906 Phase III Trial

James M. Foran, MD, Zhuoxin Sun, PhD, Elisabeth Paietta, PhD, Janis Racevskis, PhD, David F. Claxton, MD, Hillard M Lazarus, MD, Daniel A. Arber, MD, Jacob M. Rowe, MD, Jessica K. Altman, MD, Aref Al-Kali, MD, Hong Zheng, MDPhD, Keith W. Pratz, MD, Edward R. Broun, MD, Bayard L. Powell, MD, Kristen Marie O'Dwyer, MD, John Godwin, MD, Yanming Zhang, MD, Martin S. Tallman, MD, Selina Luger, MD, Mark R. Litzow, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 437.
https://doi.org/10.1182/blood-2018-99-113950
Published: 2018
Journal Articles

Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study

James M. Foran, MD, Yanming Zhang, MD, Michael Heckman, MS, Selina Luger, MD FRCPC, Cassondra Hulshizer, BA, Emily Vargas, MPH, Mark R. Litzow, MD, Jessica K. Altman, MD, Keith Pratz, MD, Ryan Mattison, MD, David F. Claxton, Geoffrey L. Uy, MD, Harry P. Erba, MD PhD, Mohamad A. Cherry, MDMS, Edward R. Broun, MD, Bayard L. Powell, MD, Hillard M Lazarus, MD, Jacob M. Rowe, MD, Elisabeth Paietta, PhD, Richard F. Little, MDMPH, Jen Poynter, PhD, Martin S. Tallman, MD, James R. Cerhan, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2579.
https://doi.org/10.1182/blood.V130.Suppl_1.2579.2579
Published: 2017
Journal Articles

Treatment of Red Cell Hypoplasia Following Fully Ablative Matched Related Allogeneic Transplant with Stem Cell Boost.

James Essell, M.D, Catherine Tierney, RN, BSN, OCN, Mary Alliston, RN, BSN, OCN, Edward R. Broun, MD
Journal: Blood
Blood (2010) 116 (21): 4530.
https://doi.org/10.1182/blood.V116.21.4530.4530
Published: 2010